Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
15%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
XBI
120
HOLDINGS
21%
ALSO IN IDNA
IDNA
44
HOLDINGS
63%
ALSO IN XBI
SECTOR DRIFT (XBI minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 2.6% | 6.1% | 2.6% |
|
REGENERON PHARMACEUTICALS | 2.1% | 5.1% | 2.1% |
|
INCYTE CORP | 1.8% | 4.9% | 1.8% |
|
EXELIXIS INC | 1.8% | 3.3% | 1.8% |
|
MODERNA, INC. | 1.6% | 3.1% | 1.6% |
XBI Overweight Relative to IDNA
|
EXACT SCIENCES CORP | 2.8% |
|
AVIDITY BIOSCIENCES INC | 2.3% |
|
INSMED INC | 2.1% |
|
NATERA INC | 2.1% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.1% |
|
BRIDGEBIO PHARMA, INC. | 2.1% |
|
IONIS PHARMACEUTICALS, INC. | 2.0% |
|
BIOGEN IDEC INC | 1.9% |
|
AMGEN INC | 1.9% |
|
UNITED THERAPEUTICS CORP | 1.9% |
XBI Underweight Relative to IDNA
|
CELCUITY INC. | -5.5% |
 |
GENMAB A/S | -4.6% |
|
MERCK & CO. INC. | -4.3% |
 |
ASTRAZENECA PLC | -4.1% |
 |
ROCHE HOLDING LTD | -3.8% |
|
GSK PLC | -3.7% |
|
REVOLUTION MEDICINES, INC. | -3.5% |
 |
SANOFI-AVENTIS | -3.2% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -3.1% |
|
INCYTE CORP | -3.1% |